Chronic Wound Infections: New Drug Combo Speeds Healing

Summary of the Article: Novel Approach to Treating Diabetic Foot Ulcers

This article details research ⁢led ⁣by Dr. Spero at the University of Oregon, focusing on a new strategy to combat chronic bacterial infections in diabetic foot ulcers. Here’s a breakdown of the key points:

* The Problem: Diabetic⁤ foot ulcers are common (affecting 1 in 4 people with ⁤Type 2 diabetes) and ‍often become⁤ infected.These infections are tough to treat due to limited oxygen in the wound, wich promotes antibiotic resistance and slow ⁤bacterial growth. Severe cases can lead to amputation (1 in 5 ulcers).
*‍ The Mechanism: ⁢ Bacteria in these oxygen-deprived wounds switch to using nitrate ⁣for energy (nitrate respiration), slowing their growth but allowing them to survive and resist ⁣antibiotics. Standard antibiotic⁢ testing is done in oxygen-rich environments and⁣ targets fast-growing bacteria, making them ineffective against these slow-growing, nitrate-respiring bacteria.
* The Solution: Dr. Spero’s research shows ⁢that combining antibiotics with a small molecule called chlorate significantly increases the antibiotics’ effectiveness. Chlorate “stresses” the bacterial cells, making them more vulnerable‍ to‍ the antibiotics.
* The Research:

* Previous studies (at Caltech) showed chlorate boosted antibiotic effectiveness in cell cultures and diabetic mouse models.
⁤ * A $1.84 million NIH grant is funding continued research at the UO.
* Recent findings demonstrate chlorate enhances the effectiveness of various antibiotics against P. aeruginosa (a common bacteria in these ⁣ulcers) and allows for significantly lower antibiotic dosages (e.g., 1% of the standard dose of ceftazidime).
* The Benefit: Lowering antibiotic dosage and treatment duration reduces the risk of harmful side effects like‍ gut microbiome disruption and toxicity.
* Next Steps: the⁢ research is currently based⁢ on lab tests ⁤and needs to be translated into clinical trials to determine its effectiveness in humans.

In essence, the research offers a promising new approach to⁢ treating stubborn infections in diabetic foot ulcers by making existing antibiotics more potent and reducing the need for high doses and prolonged treatment.